Virginia Heartburn and Hernia Institute
Lorton, Virginia, 22079, United States
NCT Number: NCT03735862
Investigator will identify a consecutive cohort of patients who have undergone a hiatal hernia repair and are at least 6 months post index procedure.
Looking for future studies?
Notify MeAll sexes
Observational
Lorton, Virginia, 22079, United States
Planned Sample Size: At minimum of 70 consecutive subjects at least 6-months post-index procedure
Study Population: A consecutive cohort of patients who have undergone a hiatal hernia repair with MIROMESH.
Primary Objective: Characterize the procedural and early post-operative safety profile of MIROMESH when used as reinforcement in hiatal hernia repair.
Secondary Objectives
A retrospective chart review will identify the appropriate cohort with a prospective follow-up survey to acquire safety and outcome information.
A retrospective chart review of appropriate subjects.
Data to be acquired will be:
Preoperative - Chart Review
Post-Operative (With-in 1 month of surgery) Preoperative - Chart Review
Prospective institutional review board approved Follow-Up Telephone Interview
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hiatal hernia repair with MIROMESH
Other names: MIROMESH Biologic Matrix
Time frame: 6-18 months post index procedure
Patient self-report if they had a revision or other laparoscopic surgery following index procedure.
Time frame: 6-18 months post index procedure
The GERD-HRQL score assess the severity of GERD symptomatic and impact on the subjects quality of life. The score is comprised of 10 questions whose answers are summed for the final score. THe score can range from 0 to 50, with 50 being the worst and 0 meaning no impact.
Time frame: 6-18 months post index procedure
Use of PPIs in 3-months prior to follow-up interview
Time frame: 6-18 Months post index procedure
Patients reported their satisfaction with the procedure as "Dissatisfied", "Neutral", or Satisfied.
Time frame: 6-18 Months post index procedure
Patients were asked to report how likely they would be to recommend this procedure to a friend or loved one with the same condition. Report was based on a scale of 1 (not at all likely) to 10 (very likely).
Miromatrix Medical Inc.
Industry
Complications and 1-Year Outcomes Following Hiatal Hernia Repair With MIROMESH a Novel, Highly Vascular, Porcine Derived, Biologic Matrix
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718828
Deglutition Disorders, Digestive System Diseases
Sofia, Sofia-Grad, Bulgaria
View Trial DetailsNCT07138235
Hernia, Hernia, Diaphragmatic
View Trial DetailsNCT07387042
Hernia, Hernia, Diaphragmatic
Minya, Egypt
View Trial DetailsNCT06926374
Adenocarcinoma, Biliary Tract Diseases
Hong Kong, China
View Trial Details